EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma

Haixia Li, Li Cao, Ruimin Li, Ling Xu, Shuxia Zhang, Jianjun Gao, Yongxue Chen, Xiaoqiang Lian

Clinical Laboratory · 2026 · 72 (05/2026)

DOI: 10.7754/clin.lab.2025.250554 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Haixia Li und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cuproptosis, Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuproptosisCarcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorTranscriptomeHumansPrognosisGene Expression ProfilingGene Expression Regulation, NeoplasticMaleFemaleMiddle AgedKaplan-Meier Estimate

Substanzen

Biomarkers, Tumor

Zitieren

APA

Li, H., Cao, L., Li, R., Xu, L., Zhang, S., Gao, J., Chen, Y., & Lian, X. (2026). Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma. Clinical Laboratory, 72(05/2026). https://doi.org/10.7754/clin.lab.2025.250554

Vancouver

Li H, Cao L, Li R, Xu L, Zhang S, Gao J, et al. Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma. Clinical Laboratory. 2026;72(05/2026). doi:10.7754/clin.lab.2025.250554

BibTeX
@article{Li2026,
  author = {Li, Haixia and Cao, Li and Li, Ruimin and Xu, Ling and Zhang, Shuxia and Gao, Jianjun and Chen, Yongxue and Lian, Xiaoqiang},
  title = {Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma},
  journal = {Clinical Laboratory},
  year = {2026},
  volume = {72},
  number = {05/2026},
  doi = {10.7754/clin.lab.2025.250554}
}
Kostenlos starten →